News
Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback